NCT03612557View on ClinicalTrials.gov

A Study of Benzathine Benzylpenicillin Intramuscular Injection in Japanese Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 20, 2018

Primary Completion Date

October 2, 2018

Study Completion Date

October 2, 2018

Conditions
Healthy
Interventions
DRUG

penicillin G benzathine

2.4 million units (IM) of benzathine benzylpenicillin

Trial Locations (1)

192-0071

P-one Clinic, Keikokai Medical Corporation, Hachioji-shi

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03612557 - A Study of Benzathine Benzylpenicillin Intramuscular Injection in Japanese Healthy Subjects | Biotech Hunter | Biotech Hunter